Pittsburgh, United States
Resilient Lifescience, founded in 2022, is a Pittsburgh-based startup making strides in the Health and Wellness and Life Sciences industries. The company's slogan, "Combating overdose with intelligent drug discovery," encapsulates its mission to address the pressing issue of opioid overdose with innovative technology.
The startup is developing a wearable medical device capable of administering naloxone automatically during an overdose, which is crucial in scenarios where immediate human intervention isn't possible. This solution could potentially save countless lives, highlighting its value proposition in the market.
Resilient Lifescience recently secured a $50.00K Pre Seed Round investment from Innovation Works and AlphaLab Health as of 06 December 2023. This early-stage financing underscores investor confidence in the company's innovative approach and its potential impact on addressing opioid addiction effectively.
